Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
An HIVer's social and economic status can be used to determine how effective antiretroviral treatment will be during initial therapy, according to a study published in the August issue of the Journal of Psychosomatic Research. The effect has even been found among subjects with high rates of drug adherence. Researchers in the study--conducted by a team from Harvard School of Public Health, Massachusetts General Hospital, Stanford University Medical School, and the American Psychological Association--used data from a clinical trial that recruited HIV-positive men and women in the United States and Italy who had not previously taken any anti-HIV medications. The study participants were then treated with combination antiretroviral therapy. Experts have previously suggested that stress and emotional distress predict a faster decline in the immune system cells that can fight HIV's progression. Previous studies have also shown that people at lower socioeconomic positions often report chronic stresses in life. The researchers in this study wanted to examine whether socioeconomic position, based on education level, would influence immune functioning and response to antiretroviral treatments--even if patients adhered to their antiretroviral drugs. The study's authors documented the length of time until a participant first experienced a regimen failure, meaning that the drug combination failed to maintain low HIV levels in the bloodstream or that anti-HIV meds needed to be changed or stopped. The researchers found that participants with lower levels of education reached initial regimen failure faster than participants with a college- or graduate-level degree. However, participants with high levels of 'adherence self-efficacy,' despite lower education levels, experienced a reduction in initial regimen failure by 15% to 17%. Adherence self-efficacy was described as a coping resource that reflected the strength of the patient's belief in the effectiveness of their medication and their ability to adhere to their treatment regimen. The authors suggest that one reason behind this association might be that coping styles are often associated with better immune functioning in individuals with HIV disease. 'These findings support health promotion programs focusing on psychological and behavioral aspects associated with therapeutic regimens,' says Linda Marc, who led the research project while a doctor of science candidate in the department of Society, Human Development, and Health at Harvard School of Public Health.
From our Sponsors
Most Popular
Lexi Love comes out as HIV+ after Trump deletes federal resources
January 23 2025 11:23 AM
Ricky Martin delivers showstopping performance for 2024 World AIDS Day
December 05 2024 12:08 PM
Trump's orders prompt CDC to erase HIV resources
January 31 2025 5:29 PM
Meet our Health Hero of the Year, Armonté Butler
October 21 2024 12:53 PM
California confirms first case of even more deadly mpox strain
November 18 2024 3:02 PM
This long-term HIV survivor says testosterone therapy helped save his life.
December 16 2024 8:00 PM
Plus: Featured Video
Latest Stories
Broadway's best raise over $1 million for LGBTQ+ and HIV causes
April 03 2025 7:15 PM
The Talk Season 5 premieres this spring with HIV guidance for the newly diagnosed
March 26 2025 1:00 PM
Discover the power of Wellness in your life
March 26 2025 12:41 PM
Season 4 of The Switch on resilience & radical self-love returns this spring
March 26 2025 12:20 PM
Jess King is here to help you live your happiest, healthiest life yet
March 24 2025 4:35 PM
BREAKING NEWS: Trump admin moves to end federal HIV prevention programs
March 18 2025 6:10 PM
Gerald Garth is keeping people of color happy and healthy through trying times
March 11 2025 3:38 PM
Celebrating Black History Month with our annual African American issue
February 01 2025 3:28 PM
Tyler TerMeer vows to continue to fight for health care for all
January 28 2025 3:00 PM
Plus nominated for 2025 GLAAD Media Award
January 22 2025 12:42 PM
A camp for HIV-positive kids is for sale. Here's why its founder is celebrating
January 02 2025 12:21 PM
'RuPaul's Drag Race' star Trinity K Bonet quietly comes out trans
December 15 2024 6:27 PM
AIDS Memorial Quilt displayed at White House for the first time
December 02 2024 1:21 PM
Decades of progress, uniting to fight HIV/AIDS
December 01 2024 12:30 PM
Hollywood must do better on HIV representation
December 01 2024 9:00 AM
Climate change is disrupting access to HIV treatment
November 25 2024 11:05 AM
Post-election blues? Some advice from mental health experts
November 08 2024 12:36 PM
Check out our 2024 year-end issue!
October 28 2024 2:08 PM
AIDS/LifeCycle is ending after more than 30 years
October 17 2024 12:40 PM
Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%
October 15 2024 5:03 PM